Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sandhaus

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
COPD|July 5, 2013
Biochemical efficacy and safety of a new, ready-to-use, liquid alpha-1-proteinase inhibitor, GLASSIA (alpha1-proteinase inhibitor (human), intravenous)Robert A Sandhaus, James Stocks, Farshid N Rouhani, et al.
Chest|May 1, 1983
Elastolytic proteinases of the human macrophageR A Sandhaus, K M McCarthy, R A Musson, et al.
COPD|February 21, 2009
Effects of a disease management program in individuals with alpha-1 antitrypsin deficiencyMichael A Campos, Saleh Alazemi, Guoyan Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2023
Health-related Quality of Life in Alpha-1 Antitrypsin Deficiency-associated Chronic Obstructive Pulmonary DiseaseRadmila Choate, Kristen E Holm, Robert A Sandhaus, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 26, 2023
Impact of Coronavirus Disease 2019 and Vaccination Attitudes on Alpha-1 Antitrypsin DeficiencyMargaret A Hay, Kristen E Holm, Jean McCathern, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 9, 2026
Severe Obesity and Alpha-1 Antitrypsin Deficiency-Associated COPD: A Dual Burden on Health and Quality of LifeRadmila Choate, Kristen E Holm, Robert A Sandhaus, et al.
Respiratory Medicine|October 16, 2024
Physical and mental health trajectories: A longitudinal SF-36 analysis in Alpha-1 antitrypsin deficiency-associated COPDRadmila Choate, Kristen E Holm, Robert A Sandhaus, et al.
BMC Pulmonary Medicine|March 19, 2024
Characteristics associated with SF-36 in alpha-1 antitrypsin deficiency-associated COPD: a cross-sectional analysisRadmila Choate, Kristen E Holm, Robert A Sandhaus, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|September 14, 2022
Patient-Reported Pulmonary Symptoms, Exacerbations, and Management in a Cohort of Patients With Alpha-1 Antitrypsin DeficiencyRadmila Choate, Robert A Sandhaus, Kristen E Holm, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 1, 2019
An analysis of the degree of concordance among international guidelines regarding alpha-1 antitrypsin deficiencyAmy Attaway, Uddalak Majumdar, Robert A Sandhaus, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
COPD|July 5, 2013
Biochemical efficacy and safety of a new, ready-to-use, liquid alpha-1-proteinase inhibitor, GLASSIA (alpha1-proteinase inhibitor (human), intravenous)Robert A Sandhaus, James Stocks, Farshid N Rouhani, et al.
Chest|May 1, 1983
Elastolytic proteinases of the human macrophageR A Sandhaus, K M McCarthy, R A Musson, et al.
COPD|February 21, 2009
Effects of a disease management program in individuals with alpha-1 antitrypsin deficiencyMichael A Campos, Saleh Alazemi, Guoyan Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2023
Health-related Quality of Life in Alpha-1 Antitrypsin Deficiency-associated Chronic Obstructive Pulmonary DiseaseRadmila Choate, Kristen E Holm, Robert A Sandhaus, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 26, 2023
Impact of Coronavirus Disease 2019 and Vaccination Attitudes on Alpha-1 Antitrypsin DeficiencyMargaret A Hay, Kristen E Holm, Jean McCathern, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 9, 2026
Severe Obesity and Alpha-1 Antitrypsin Deficiency-Associated COPD: A Dual Burden on Health and Quality of LifeRadmila Choate, Kristen E Holm, Robert A Sandhaus, et al.
Respiratory Medicine|October 16, 2024
Physical and mental health trajectories: A longitudinal SF-36 analysis in Alpha-1 antitrypsin deficiency-associated COPDRadmila Choate, Kristen E Holm, Robert A Sandhaus, et al.
BMC Pulmonary Medicine|March 19, 2024
Characteristics associated with SF-36 in alpha-1 antitrypsin deficiency-associated COPD: a cross-sectional analysisRadmila Choate, Kristen E Holm, Robert A Sandhaus, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|September 14, 2022
Patient-Reported Pulmonary Symptoms, Exacerbations, and Management in a Cohort of Patients With Alpha-1 Antitrypsin DeficiencyRadmila Choate, Robert A Sandhaus, Kristen E Holm, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 1, 2019
An analysis of the degree of concordance among international guidelines regarding alpha-1 antitrypsin deficiencyAmy Attaway, Uddalak Majumdar, Robert A Sandhaus, et al.
Pageof 12